MedTrace Logo

A Promising Tool for Predicting Consciousness Evolution in Prolonged Disorders of Consciousness

NCT02948660 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2022-05-31

No results posted yet for this study

Summary

The research contains two parts. Part 1: To explore whether EEG responses to zolpidem can assess consciousness circuit integrity and predict the evolution of consciousness in patients with prolonged disorders of consciousness; Part 2: To explore if quantitative EEG reactivity might predict the prognosis of disorders of consciousness.

Conditions

  • Disorder of Consciousness

Interventions

DRUG

Zolpidem Tartrate Tablets

All participants were administered 10 mg of zolpidem tartrate tablets either via a feeding tube (for patients with prolonged disorders of consciousness) or orally.

Sponsors & Collaborators

  • Guangzhou University of Chinese Medicine

    collaborator OTHER

  • University of Melbourne

    collaborator OTHER

  • Tianjin University

    collaborator OTHER

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Wen Jiang, doctor · Department of Neurology, Xijing Hospital, Fourth Military Medical University

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02948660 on ClinicalTrials.gov